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The primary cilium is required for Sonic hedgehog
(Shh) signaling in vertebrates. In contrast to mutants
affecting ciliary assembly, mutations in the intrafla-
gellar transport complex A (IFT-A) paradoxically
cause increased Shh signaling. We previously
showed that the IFT-A complex, in addition to its
canonical role in retrograde IFT, binds to the tubby-
like protein, Tulp3, and recruits it to cilia. Here, we
describe a conserved vertebrate G-protein-coupled
receptor, Gpr161, which localizes to primary cilia in
a Tulp3/IFT-A-dependent manner. Complete loss of
Gpr161 in mouse causes midgestation lethality and
increased Shh signaling in the neural tube, phenoco-
pying Tulp3/IFT-A mutants. Constitutive Gpr161
activity increases cAMP levels and represses Shh
signaling by determining the processing of Gli3 to
its repressor form. Conversely, Shh signaling directs
Gpr161 to be internalized from cilia, preventing its
activity. Thus, Gpr161 defines a morphogenetic
pathway coupling protein kinase A activation to
Shh signaling during neural tube development.
INTRODUCTION
Long ignored as vestigial organelles, primary cilia have now been
established as sensory antennae for a wide variety of cells.
These subcellular compartments are primarily composed of
microtubule-based axonemes, which are templated from basal
bodies and ensheathed by the specialized ciliary membrane.
The axoneme is assembled and maintained by a conserved
process called intraflagellar transport (IFT) (Rosenbaum and
Witman, 2002), whereas the ciliary membrane organizes
signaling receptors fundamental for sensation (Pazour and
Bloodgood, 2008). This is most apparent in the case of modified
cilia; for example, olfactory neuronal cilia house olfactory210 Cell 152, 210–223, January 17, 2013 ª2013 Elsevier Inc.G-protein-coupled receptors (GPCRs) and respond to odorants,
whereas the vertebrate photoreceptor outer segments mediate
phototransduction by opsins. Similarly, primary cilia in neurons
respond to a wide variety of neuroendocrine signals via ciliary
GPCRs. The full complement of ciliary receptors and their down-
stream effectors thus determine the sensory signaling of cells
in specific contexts.
Graded morphogen signals provide spatiotemporal infor-
mation organizing cellular differentiation in many developmental
contexts. Particularly, in the vertebrate neural tube, a gradient
of Shh, secreted from the ventrally located notochord and floor
plate, patterns the ventral neuroepithelium into five progenitor
domains that generate distinctive neuronal subtypes (Ericson
et al., 1997). In the absence of Shh signaling, ventral neural cell
fates are lost (Chiang et al., 1996). The primary cilium is funda-
mentally important in transducing Shh signals in these neuro-
epithelial cells (Huangfu et al., 2003). Mutants affecting ciliary
assembly exhibit loss of the ventral cell types specified by high
levels of Shh. The genes disrupted in these mutants encode
components of the IFT machinery, including the IFT-B complex
(implicated in anterograde IFT), as well as the anterograde and
retrograde IFT motors (Goetz and Anderson, 2010). Paradoxi-
cally, mutations in the IFT-A complex (implicated in retrograde
IFT) result in increased Shh signaling in the caudal neural tube.
Null or hypomorphic alleles of IFT-A subunits (Thm1/Ift139alien,
Ift122sopb, and Ift144twt) exhibit dorsal expansion of the floor
plate, V3 progenitor, and motor neuron domains (Liem et al.,
2012; Ocbina et al., 2011; Qin et al., 2011; Tran et al., 2008).
Alleles resulting in severe disruption of the IFT-A complex
(Ift144dmhd or combined mutations of two IFT-A subunits) result
in strongly disrupted ciliary morphology. Although neural tube
genes characteristic of the highest levels of Shh signaling
(floor plate and V3 progenitors) fail to be induced in these
mutants, there is a dorsal expansion of genes that require inter-
mediate levels of signaling (motor neurons) (Liem et al., 2012).
The opposing neural tube phenotypes of IFT-A from other
IFT mutants suggest that the IFT-A complex has additional
‘‘preciliary’’ functions in addition to its postulated role in retro-
grade IFT.
The Shh signaling pathway requires two branches: a basal
repression mechanism that switches ‘‘off’’ the target genes
and a Shh ligand-dependent switch for turning these tar-
gets ‘‘on.’’ The primary cilium in the vertebrate neuroepithe-
lial cells acts as a regulatable platform coordinating these
opposing switches. In the absence of Shh, Gli transcription
factors, which are the key effectors of the pathway, are pro-
teolytically processed to Gli repressor forms (GliRs) (Jiang and
Struhl, 1998; Wang et al., 2000). Upon exposure to Shh, produc-
tion of GliRs is blocked, and activated Gli transcription factors
(GliAs) turn on the expression of target genes (Humke et al.,
2010; Wang et al., 2000; Wen et al., 2010). The cAMP-activated
kinase, protein kinase A (PKA), functions at the base of the cilium
and is pivotal in regulating the ‘‘off’’ switch by mediating the pro-
cessing of Glis into GliRs (Tuson et al., 2011; Wang et al., 2000).
Hypothetically, the temporal increase in cAMP could be medi-
ated either by adenylyl cyclases or regulation by cAMP-phos-
phodiesterases. However, the signals that mediate the activation
of PKA and subsequent ‘‘tuning’’ of the basal repression
machinery in Shh signaling remain unknown.
The key findings in our paper potentially resolve these two
fundamental mysteries in Shh signaling and provide a common
answer for 1) the inputs that determine cAMP-regulated PKA
activation in basal repression of Shh signaling and 2) the mech-
anism mediating antagonism of Shh pathway by IFT-A. A clue to
the second mystery became apparent in our recent discovery
that the tubby family protein Tulp3 binds to the core IFT-A
subcomplex (Mukhopadhyay et al., 2010). In addition to its
known role in retrograde transport, the core IFT-A subcomplex
recruits TULP3 to the cilia through this direct interaction (Mukho-
padhyay et al., 2010; Qin et al., 2011). Further, TULP3 promotes
trafficking of specific rhodopsin family GPCRs to cilia, which
requires both its IFT-A- and phosphoinositide-binding domains
(Mukhopadhyay et al., 2010). As mutations in Tulp3 phenocopy
IFT-A mutants (Norman et al., 2009; Patterson et al., 2009), our
results suggested that a GPCR could be important in the
Tulp3/IFT-A-regulated antagonism of Shh signaling.
As ciliary trafficking of Smoothened (a frizzled family GPCR
that positively regulates the Shh pathway) (Corbit et al., 2005;
Zhang et al., 2001) is not controlled by Tulp3/IFT-A (Mukhopad-
hyay et al., 2010; Qin et al., 2011), we reasoned that another
GPCR could mediate the observed defects in neural tube
patterning. The criteria for this GPCR would be that it is 1) local-
ized to cilia, 2) regulated by Tulp3/IFT-A, 3) conserved among
vertebrates, 4) expressed early during neural tube development,
and 5) a negative regulator of the Shh pathway. Here, we
describe Gpr161, a rhodopsin family GPCR, which satisfies all
of these criteria. Furthermore, constitutive activity of Gpr161
increases cellular cAMP levels, suggesting it to be a candidate
GPCR for establishing the basal cAMP gradient and activation
of PKA. Lastly, Shh signaling results in internalization of
Gpr161 from cilia, preventing its activity.
RESULTS
The Orphan GPCR Gpr161 Localizes to the Primary Cilia
We conducted a preliminary screen to identify ciliary GPCRs
expressed early during mouse embryonic development bytransfecting C-terminal green fluorescent protein (GFP) fusions
of candidate GPCRs in cultured IMCD3 cells. We found that the
GPCR previously implicated in the vacuolated lens mouse,
Gpr161 (Matteson et al., 2008), was localized to the primary
cilia. To determine the endogenous localization of this receptor,
we developed an affinity-purified rabbit polyclonal antibody
against a C-terminal peptide of Gpr161. Using this antibody,
we could detect Gpr161 in the cilia of a variety of cultured cili-
ated cells, including IMCD3 cells, E10.5 (or later) mouse embry-
onic fibroblasts (MEF) (Figure 1A), and NIH 3T3 fibroblasts, and
we could detect it weakly in retinal pigmented epithelial cell
lines (RPE-hTERT) (data not shown). Staining for the GPCR
upon knockdown of Gpr161 using siRNAs or in E10.0 Gpr161
knockout MEFs (see later) abrogated ciliary staining, showing
that the antibody was specific (Figure 1B and Figure S1A
available online). We were also able to detect this receptor in
virtually all cilia of cultured E16 mouse hippocampal neurons
and to detect it broadly in the cilia of pyramidal neurons in
the CA1/CA2 regions of adult mouse hippocampus (Figures
1A and S1B). Thus, Gpr161 is localized endogenously to the
primary cilia of a wide variety of ciliated cells, fulfilling the first
of our criteria.
Gpr161 Localizes to the Cilia in a Tulp3- and
IFT-A-Dependent Manner
We previously demonstrated that Tulp3 directs ciliary localiza-
tion of a subset of rhodopsin family GPCRs using heterologous
cultured cell lines (Mukhopadhyay et al., 2010). We therefore
tested whether Tulp3 also regulates localization of endogenous
Gpr161. Upon knockdown of Tulp3 using siRNA in IMCD3
cells, ciliary localization of Gpr161 was severely reduced (Fig-
ure 1B). The IFT-A core complex (comprised of Ift144, Ift140,
and Ift122) binds to Tulp3 and provides ciliary access to
Tulp3 (Mukhopadhyay et al., 2010). We cultured Ift122 null
(Ift122sopb) and wild-type primary MEFs isolated from E10.5
embryos (Qin et al., 2011) and determined whether Gpr161
localization to the cilia was affected. Whereas Gpr161 was local-
ized to 50% cilia in the wild-type cells, its localization was
severely reduced in the cilia of Ift122sopb MEFs (Figures 1A
and 1C). This suggests that the ciliary localization of Gpr161
requires Tulp3 and IFT-A and fulfils another of our criteria for
a candidate GPCR.
The Third Intracellular Loop of Gpr161 Is Both
Necessary and Sufficient for Its Ciliary Localization
To determine the minimal sequence required for ciliary localiza-
tion of Gpr161, we examined phylogenetically related GPCRs.
Gpr161 is a class A rhodopsin family GPCR, highly conserved
among vertebrates, and most closely related to another orphan
receptor, Gpr101 (Figures 1D and S1C). Both are closely related
to a1 adrenergic receptors (Adra1a, Adra1b, and Adra1d;
Figure S1C). GPR101 is not localized to the cilia (Figure 1E),
and the third intracellular loops and the C termini are most diver-
gent between GPR101 and Gpr161. Deleting a portion of the
third intracellular loop of Gpr161 prevented its localization to
the cilia, suggesting this region to be necessary (Figures 1D
and 1E). Furthermore, swapping the third intracellular loop of
GPR101 with that of Gpr161 resulted in trafficking to the cilia,Cell 152, 210–223, January 17, 2013 ª2013 Elsevier Inc. 211
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Figure 1. Gpr161 Is Localized to the Primary Cilia
(A) IMCD3 cells and wild-type primary E10.5 MEFs were grown to confluency and then starved for 24 hr before fixing and immunostaining for Gpr161 (green), and
the axonemal marker acetylated tubulin (AcTub; red). Note that, among the MEFs, the cilium with or without Gpr161 is marked with an arrow and arrowhead,
respectively. Primary hippocampal neurons cultured from E16 mice were fixed after 8 days in vitro (DIV8) and were immunostained for Gpr161 (green), Adenylyl
cyclase III (ACIII) (antibody tagged with DyLight 594; Red), and Sstr3 (not shown). Gpr161 and Sstr3 both colocalize to the cilium of the hippocampal neuron
marked with an arrow (not shown). Scale, 5 mm.
(B) IMCD3 cells were transfected with the indicated siRNAs for 72 hr and serum starved for the last 24 hr before fixing and staining for Gpr161 and acetylated
tubulin.
(C) Wild-type and Ift122sopb primary E10.5 MEFs were grown to confluency and starved for 48 hr before fixing and immunostaining for Gpr161 and acetylated
tubulin. Data are summarized from three experiments in (B) and (C) and are represented as mean ±SD; *p < 0.05 and **p% 0.001 with respect to control siRNA-
treated (B) or wild-type (C) cells.
(legend continued on next page)
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suggesting this region to be sufficient for ciliary localization
(Figure 1E). Site-directed mutagenesis of conserved residues
in the third intracellular loop of Gpr161 fine mapped the minimal
sequence to five amino acids ((I/V)KARK; referred to as ‘‘mut1’’
region in Figure 1D), a motif different from previously published
ciliary localization sequences (Berbari et al., 2008) (Figures 1D
and 1E).
Complete Loss of Gpr161 in the Mouse Leads to
Midgestation Lethality
The vacuolated lens (vl) mutation was previously reported as
a hypomorphic allele of Gpr161, which arose spontaneously in
an inbred background (Matteson et al., 2008; Wilson and Wyatt,
1986). This mutation results in lethality in50% of the vl/vlmice,
showing lumbar-sacral spina bifida. The surviving adult vl/vl
mice display congenital cataracts and vacuolation in the lens.
Positional cloning indicated a deletion mutation that truncates
the C-terminal tail of Gpr161 (Matteson et al., 2008). AsGpr161vl
is not a null allele, we decided to investigate a likely null allele of
Gpr161, created by deletion of most of the third exon and
predicted to result in truncation of Gpr161 after the initial
30 amino acids (Figures S2A–S2C; Experimental Procedures).
We observed that mice homozygous for this allele were embry-
onic lethal by E10.5 with extensive craniofacial abnormalities
and open forebrain/midbrain regions (E9.5: Figures 2A–2A’’,
2B–2B’’, and 2D–2D’). Dorsal telencephalon markers (Foxg1
and Gli3) were not detected in the cephalic region (Figures
S2F–S2F’ and S2H–S2H’), whereas Nkx2.1, which marks the
ventral telencephalon and diencephalon, was present in the
knockout embryos (Figures S2G–S2G’) (Shimamura et al.,
1995). Craniofacial defects were identifiable as early as the
8–10 somite stage (Figures S2D–S2D’ and S2E–S2E’) and bore
a striking resemblance to embryos lacking Suppressor of fused
(Sufu) (Sva¨rd et al., 2006; Wang et al., 2010). The developing
spinal cord was closed in the majority of the embryonic axis
except in the most caudal regions (Figure 2B’). In addition, there
was no sign of limb morphogenesis even by E10.0 (E9.5: Fig-
ure 2B’), and the apical ectodermal ridge of the limb bud,marked
by Fgf8, was absent (Figures S2I–S2I’). In zebrafish, morpholino-
mediated knockdown of Gpr161 results in aberrant looping
of the heart tube (Leung et al., 2008). In contrast, directionality
of cardiac looping was not affected in Gpr161 knockout
embryos, and up until E10.0, cardiac contractions were
observed. The heterozygous embryos had no characteristic
defects and essentially resembled wild-type embryos.
Expression of Gpr161
Due to the relatively low-level abundance of the Gpr161 tran-
script, we analyzed the expression pattern of Gpr161 using
radiolabeled riboprobes. As reported previously, using digoxige-(D)Multiple sequence alignment of the third intracellular loop of the vertebrate hom
(E) The ciliary localization signal of Gpr161 is both necessary and sufficient for cilia
checked for ciliary localization in transfected cells. +++ refers to >70% cilia con
Gpr161 in transfected cells. As it is difficult to correctly determine nontransfec
a qualitative estimate.
See also Figure S1.nin labeled probes, we found that Gpr161 is expressed ubiqui-
tously at low levels in E8.5 and E9.5 embryos (Figures S2C,
S2J–S2J’, and S2K–S2K’) (Matteson et al., 2008). However,
byE10.5, it was expressedprominently in theneural tube (Figures
2E–2E’’ and Figures S2L–S2L’’). At later embryonic stages (E12.5
and E15.5), Gpr161 was expressed predominantly in the brain,
spinal cord, and dorsal ganglia and was weakly expressed in
the hindlimb (Figures 2F–2F’’). Contrary to the previous report
(Matteson et al., 2008), we did not detect Gpr161 enrichment in
the lateral neural folds but detected it instead throughout the
neural tube (Figures 2E, 2F, and S2J–S2L). We also detected
low levels of expression in a variety of tissues, including the
kidney stroma and retina at E15.5 (data not shown). In summary,
Gpr161wasexpressedbroadly in thenervous system throughout
development, satisfying another of our criteria.
Gpr161 Knockout Embryos Exhibit Increased
Shh Signaling
As the ciliary localization of Gpr161 is dependent on IFT-A/Tulp3
(Mukhopadhyay et al., 2010; Qin et al., 2011), we tested whether
Shh signaling is impacted in Gpr161 mutants by analyzing the
expression of direct transcriptional targets of the Shh pathway,
Patched1 (Ptch1, the gene encoding the receptor for Shh) and
Gli1. We detected increased levels of both transcripts and
increased Gli1 protein levels in the knockout embryos as early
as the 10–12 somite stage (E9.5: Figures 3A and 3B; E8.5:
Figures S3A and S3B). We also examined embryonic expression
of these targets by RNA in situ hybridization. In the wild-type
neural tube, these targets are expressed ventrally in response
to Shh signaling. In Gpr161 mutants, Ptch1 and Gli1 expression
were additionally detected ectopically in the dorsal regions of the
neural tube as early as the 10–12 somite stage (Gli1: Figure 3C;
Ptch1: Figures 3E and 3F). It is possible that this increase in
expression of target genes results from increased production
of the Shh ligand. However, Shh expression was confined to
its normal domains (the notochord and floor plate at E9.5 or
notochord at E8.5) (Figure 3D), with expanded domains only in
the caudal neural tube (Figure S3F). We also looked at expres-
sion patterns for the other Gli transcription factors. Expression
of Gli3 is normally restricted to dorsal regions by Shh signaling,
and this gene showed reduced overall expression in Gpr161
mutants (Figure S3E). The expression domain of Gli2 was
roughly similar between genotypes (data not shown). Similarly,
there was a modest decrease in Gli3 transcript levels, but not
of Gli2 (Figure S3C). Gli3 RNA expression is downregulated by
Shh signaling (Bai et al., 2004; Wang et al., 2000), and the
changes in Gli3 RNA levels in the Gpr161 mutants are likely to
be a consequence of activation of the Shh pathway. In summary,
these data indicate that Gpr161 mutants experience elevated
levels of Shh pathway activity.ologs of Gpr161. Site-directedmutants of conserved regions are shown below.
ry localization. IMCD3 cells were transfected with the indicated constructs and
sistently strongly positive for Gpr161, and ++ refers to 70% cilia positive for
ted cells in a population, the distribution of transfected cells is provided as
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Figure 2. Gpr161 Knockout Causes Midgestation Lethality
(A and B) E9.5 wild-type andGpr161 knockout embryos are shown. A’, A’’, B’, and B’’ are scanning EM pictures. A, A’, B, and B’ are lateral views, whereas A’’ and
B’’ are en face images. Asterisks in B’ indicate craniofacial defects, open caudal neural tube, and lack of limb buds.
(C) Cartoon showing sections in later panels.
(D and D’) PFA-fixed hematoxylin/eosin-stained transverse sections from the cephalic region. The asterisk in D’ points to the open forebrain.
(legend continued on next page)
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Figure 3. Gpr161 Knockout Embryos Show
Increased Shh Signaling
(A)Gli1andPtch1 transcript levels inwhole-embryo
lysates at E9.5. Individual estimations were done
in triplicate and are represented as mean ±SD.
(B) Immunoblotting for Gli1, Gli3, and a-tubulin in
whole-embryo lysates at E9.5. Quantification
(mean ±SD) of relative amounts of Gli1 and Gli3
(normalized to respective a-tubulin levels) from
two different experiments is shown at the bottom
of each immunoblot. Abbreviations: Gli3FL, Gli3
full length; Gli3R, Gli3 repressor.
(C) RNA in situ hybridization for Gli1 in E9.5
(thoracic spinal cord region) and E8.5 embryos
(10–12 somite stage; midtrunk region).
(D) RNA in situ hybridization for Shh in E9.5
(thoracic spinal cord region) and E8.5 embryos
(10 somite stage; trunk region).
(E) Whole-mount RNA in situ hybridization for
Ptch1 in E9.5 embryos (lateral views).
(F) RNA in situ hybridization for Ptch1 in E9.5
(caudal spinal cord region) and E8.5 embryos
(10 somite stage; trunk region). Ventral is to the
bottom in (C), (D), and (F). The extent of hybrid-
ization is marked by lateral bars in (C) and (F).
In all panels, genotypes are marked as: wild-type
(+/+); Gpr161 heterozygous (+/); and Gpr161
knockouts (/). *p < 0.05, **p < 0.01, and ***p <
0.001 with respect to corresponding wild-type
levels. Scales for (E), 1 mm; scales for (C), (D), and
(F), 100 mm. See also Figure S3.Gpr161 Knockout Mice Exhibit a Ventralized
Neural Tube
IFT-A and Tulp3 mutant embryos show an expansion of Shh-
dependent ventral cell types in the developing neural tube
(a ‘‘ventralization’’ phenotype) (Norman et al., 2009; Ocbina
et al., 2011; Patterson et al., 2009; Qin et al., 2011; Tran et al.,
2008). We next ascertained whether Gpr161 knockout embryos
are similarly affected. By E9.5, Shh-dependent ventral cell types
were ectopically specified at the expense of lateral anddorsal cell
types, throughout the spinal cord and hindbrain of Gpr161(E and F) RNA in situ hybridization with radiolabeled antisense (E and F), or sense riboprobes (E’ and F’) forGp
sagittal sections of E12.5 (F and F’) in thewild-type background. Cresyl violet staining of the corresponding sec
are as follows: wild-type (+/+) andGpr161 knockout (/). Abbreviations: FB, forebrain; HB, hindbrain; HL, hin
OV, optic vesicle.
Scale for (A) and (B), 1 mm; (A’), (A’’), (B’), (B’’), (D), and (D’’), 0.5 mm; (E–E’’) and (F–F’’), 2.5 mm. See also F
Cell 152, 210–223,mutants. Specifically, floor plate progeni-
tors expressing FoxA2, p3 progenitors
expressing Nkx2.2, pMN progenitors
expressing Olig2, and p3/pMN/p2
progenitors expressing Nkx6.1 showed
enlarged expression domains, expanding
into comparatively more dorsal regions
and showing notable intermingling of
markers (Figure 4 and Movies S1, S2,
S3, and S4). Shh signaling also inhibits
the specification of lateral and dorsal
neural cell types. In Gpr161 mutants,markers for these cell types were either strongly downregulated
(Pax7) or were expressed in dorsally restricted domains (Pax6)
(Figure 4 and Movies S5 and S6). We could detect defects in
dorso-ventral patterning as early as the 8–10 somite stage, at
a time when the Nkx6.1- and FoxA2-expressing domains were
expanded dorsally in the neural tube (Figure S4). This expansion
was followed by a further expansion of the Olig2-expressing
domain by the 10–12 somite stage (Figure S4). Although similar
to mouse embryos with IFT-A complex and Tulp3 mutations,
the ventralization phenotype was not only limited to the caudalr161 in transverse sections of E10.5 (E and E’) and
tions is shown in E’’ and F’’. Genotypes of embryos
d limb; Lb, limb bud;MB,midbrain; NT, neural tube;
igure S2.
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Figure 4. Gpr161 Knockout Embryos Exhibit Ventralization of the
Neural Tube
E9.5 spinal cord sections (thoracic region) from wild-type (+/+) and Gpr161
knockout (/) embryos immunostained for Pax7, Pax6, Nkx6.1, Olig2,
Nkx2.2, and FoxA2 (counterstained with Hoechst, blue). The extent of markers
in each background is marked by lateral bars, and red arrowheads mark the
ectopic dorsal expression of FoxA2 in the Gpr161/ mutant. Scale, 100 mm.
See also Figure S4 and Movies S1, S2, S3, S4, S5, and S6.
216 Cell 152, 210–223, January 17, 2013 ª2013 Elsevier Inc.neural tube but instead extended throughout the spinal cord and
the hindbrain (Movies S1, S2, S3, S4, S5, and S6).
Gpr161 Knockout Mice Exhibit Gli3/Gli2 Processing
Defects
In the absence of Shh ligand, PKA-mediated phosphorylation of
Gli3 results in its limited proteolysis into Gli3R (Jiang and Struhl,
1998; Wang et al., 2000). In Gpr161 mutant embryos, the extent
of Gli3 processing into Gli3R at E8.5 (and later stage) whole-
embryonic extracts was strongly decreased compared to
wild-type (E9.5: Figure 3B; E8.5: Figure S3B), suggesting that
Gpr161 directs processing of Gli3 into Gli3R. Shh signaling inac-
tivates PKA kinase activity, preventing this limited proteolysis.
Subsequently, activated full-length Gli proteins are formed that
are unstable (Chen et al., 2009; Humke et al., 2010; Jia et al.,
2009; Wang et al., 2010; Wen et al., 2010). In Gpr161 mutants,
the full-length forms of both Gli3 and Gli2 were moderately
reduced (E9.5: Figures 3B and S3D; E8.5: Figure S3B), similar
to but less severe than in mutants with complete loss of PKA
activity (PKA null) or Sufu (Tuson et al., 2011; Wang et al.,
2010). This suggests that the absence of Gpr161 leads to acti-
vation of the Gli proteins, which is consistent with the strongly
ventralized neural plate of the mutants. In summary, the
Gpr161 mutants exhibit a ventralized neural tube phenotype
and Gli processing defects suggestive of increased Shh
signaling, satisfying the final requirement of our criteria.
Shh Pathway Activation in Gpr161 Mutants Is
Independent of Smo
Tulp3/IFT-A does not control trafficking of Smo to cilia (Mukho-
padhyay et al., 2010), and activation of the Shh pathway in
Tulp3 and IFT-A mutants is Smo independent (Norman et al.,
2009; Ocbina et al., 2011; Qin et al., 2011). Mice mutants for
Smo exhibit embryonic arrest by E9.5 and defects in the ventral
midline, including cyclopia and dorsalization of the neural tube
(Zhang et al., 2001). The growth retardation defect caused by
the disruption of Smo was completely suppressed in Smo/
Gpr161 double mutants, and the craniofacial abnormalities
were similar to that of Gpr161 single mutants (Figure 5A). Simi-
larly, the expansion of ventral identity markers (Nkx2.2, Olig2,
and Nkx6.1) and dorsal restriction of Pax6 occurred in Smo/
Gpr161 double mutants as in Gpr161 single mutants (Figures
5A and S5A). Although the immunostaining of themarker for floor
plate progenitors, FoxA2, in the double mutant was weaker than
the Gpr161 single mutant, clear ectopic expression was evident
in the dorsal neural tube (Figure S5A). These floor plate progeni-
tors require maximal Shh signaling, and the inability of full restitu-
tion in the double knockout (in comparison to the Gpr161 single
mutant) suggests lack of fully active Shh signaling in the absence
of Smo. Mostly, however, similar to Tulp3 and IFT-A, Gpr161 is
epistatic to Smo. Thus, the ventralization phenotype in Gpr161
mutants occurs largely independently of Smo and suggests its
role in the basal repression machinery of Shh signaling.
Shh Pathway Activation in Gpr161 Mutants Requires
Kif3a
Primary cilia are critical for Shh signaling in vertebrates. Disrup-
tion of the anterograde IFT motor kinesin II subunit, Kif3a, results
Figure 5. Neural Tube Patterning in Smo/
Gpr161 and Kif3a/Gpr161 Double Mutants
(A and B) Sections through thoracic (A) and
lumbar (B) spinal cord regions of E9.5 wild-type,
Gpr161/, Smo/, Kif3a/, Smo/Gpr161/,
and Kif3a/Gpr161/ mutants stained for Pax6,
Nkx6.1, and Nkx2.2 (counterstained with Hoechst,
blue). The extent of markers is marked by lateral
bars. Craniofacial abnormalities typical of
Gpr161/ single mutants (A and B) are marked by
asterisks, and cyclopia in the Smo/mutant (A) is
marked by an arrowhead. The cardiac looping in
Kif3a/ and Kif3a/Gpr161/ embryos in (B) is
designated by arrows. The Kif3a/Gpr161/
embryo shown in the figure exhibits reversed
cardiac looping, as do some of the Kif3a/
embryos (not shown; Marszalek et al., 1999).
Magnifications for whole-embryo images:322 in
(A). Scale for whole-embryo images in (B), 1 mm;
scale for cryosections in (A) and (B), 100 mm.
(C) Gli1 and Ptch1 transcript levels in whole-
embryo lysates at E9.5. Individual estimations
were done in triplicate and are represented as
mean ±SD; *p < 0.001 with respect to corre-
sponding wild-type levels.
(D) Immunoblotting for Gli1, Gli3, and a-tubulin in
whole-embryo lysates at E9.5. Abbreviations as in
Figure 3B. In (C) and (D), respective genotypes are
marked as: wild-type (+/+); heterozygous (+/);
and knockouts (/).
See also Figure S5.in defective ciliogenesis and a loss of ventral cell types specified
by high levels of Shh in the neural tube (Huangfu et al., 2003).
However, Sufu acts as a negative regulator of mammalian Shh
signaling independent of cilia (Chen et al., 2009; Jia et al.,
2009). We investigated whether the Gpr161 mutant phenotype
is dependent on cilia by generating Kif3a/Gpr161 double
mutants. Kif3a single mutants are smaller than wild-type
embryos and arrest around E9.5 (Marszalek et al., 1999). The
general morphology and neural patterning of Kif3a/Gpr161
double mutants resembled that of Kif3a single mutants (Figures
5B and S5B). At the E9.5 stage, the increase in Gli1 protein levels
and Gli1/Ptch1 transcript levels in Gpr161 knockout E9.5
embryos were suppressed in theGpr161/Kif3a double-knockout
embryos (Figures 5C, 5D, and S5C). In addition, both the Kif3a
mutants (Humke et al., 2010; Wen et al., 2010) and the
Gpr161/Kif3a double mutants had significantly lower levels of
Gli3R but equivalent levels of Gli3FL compared to wild-type or
Gpr161 heterozygous embryos (Figure 5D). Thus, the activation
of the Shh pathway resulting from disruption of Gpr161 depends
on kinesin II. Although kinesin II is known to play other roles inCell 152, 210–223addition to IFT (Bananis et al., 2004), its
role in neural tube patterning is primarily
mediated through primary cilia, suggest-
ing the parsimonious model that lack
of Gpr161 activates Shh pathway in this
compartment. The morphology of cilia
was not grossly affected in the Gpr161
knockout embryos or in E10.0 knockoutMEFs (Figures S5D and S5E). A similar test of dependence of
the Gpr161 phenotype on the central Shh pathway regulator,
Gli2, was not possible because of close genetic linkage
(Extended Experimental Procedures).
Gpr161 Is Removed from the Cilia upon Treatment
with Shh
Because of the elaborate coupling between spatial patterning
and timing in the developing neural tube, we considered the
model that the Gpr161 pathway itself would need to be inacti-
vated as Shh signaling became fully activated. We tested the
most direct mechanism, wherein activation of Shh would directly
inactivate Gpr161 in cilia. Remarkably, treatment with Shh re-
sulted in complete loss of endogenous Gpr161 from cilia within
2 hr in IMCD3 cells (Figure 6A). Treatment with SAG or pur-
morphamine, which directly activate Smo (Sinha and Chen,
2006), was also equally effective in removing Gpr161LAP from
cilia of NIH 3T3 cells (Figures 6B and 6C). Furthermore, treatment
with the oxysterol 20a-hydroxycholesterol, which can act as
a Smo agonist, but not with the related inactive oxysterol, January 17, 2013 ª2013 Elsevier Inc. 217
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Figure 6. Regulation of Gpr161 Localization
(A) Gpr161 is internalized from cilia upon Shh
treatment. IMCD3 cells were grown to con-
fluency, starved for a total of 21 hr, and treated
with octyl-Shh for indicated time periods at
the end. Cells were probed for endogenous
Gpr161 using immunofluorescence and scored
for ciliary localization (by counterstaining with
acetylated tubulin). Data are represented as
mean ±SD.
(B) Role of agonists and antagonists in Shh
pathway in Gpr161 internalization. NIH 3T3 lines
stably expressing Gpr161LAP were grown until
confluency and then starved and treated with
indicated reagents for 22 hr. Cells were immuno-
stained for acetylated tubulin and estimated for
Gpr161LAP localization in cilia. Concentrations of
chemicals are as follows: octyl-Shh (300 ng/ml),
SAG (250 nM), Purmomorphamine (Purmo;
10 mM), HhAntag (HhAnt; 250 nM), 20a-hydrox-
ycholesterol (20-OHChl; 5 mM), and 7b-hydrox-
ycholesterol (7-OHChl; 5 mM). As the oxysterols
were dissolved in chloroform (CHCl3), the control
for estimating their effect was adding equivalent
amounts of CHCl3. Data are represented as mean ±SD; *p < 0.001 with respect to DMSO- or CHCl3-treated cells.
(C) NIH 3T3 lines stably expressing Gpr161LAP were processed with indicated reagents as in (B). Cells were immunostained for acetylated tubulin (Actub;
magenta) and counterstained with Hoechst (blue). Cilia are marked by white arrows.
See also Figure S6.(7b-hydroxycholesterol) (Nachtergaele et al., 2012), had similar
effects (Figure 6B). The effect of Shh treatment on receptor
removal was suppressed in the presence of the small-molecule
inhibitors of Smo, HhAntag (Frank-Kamenetsky et al., 2002;
Romer et al., 2004), and cyclopamine (Chen et al., 2002), sug-
gesting that active Shh signaling is required for its ciliary exit
(Figures 6B, 6C, and S6A). Importantly, total Gpr161LAP protein
levels were not affected following treatment with Shh as seen
by immunoblotting (Figure S6B). The receptor was internalized
into the recycling endocytic compartment as designated by
labeling with endocytosed transferrin (Figure S6C). Thus
Shh signaling itself prevents Gpr161 signaling by removing it
from cilia.
Basal Activity of Gpr161 Results in Increased cAMP
Levels
The defects in Gli processing in Gpr161 mutants are strongly
reminiscent of similar defects in PKA null (Tuson et al., 2011)
or Sufu mutants (Wang et al., 2010) and could be mediated
by either PKA or Sufu. In order to discriminate between these
possibilities, we investigated Gpr161-mediated downstream
signaling. Agonist-independent constitutive signaling has now
been observed for a wide variety of GPCRs (Leurs et al., 1998;
Seifert and Wenzel-Seifert, 2002). In the absence of a known
ligand,we looked for constitutive activity ofGpr161by generating
doxycycline-inducible stable cell lines expressing the untagged
wild-type receptor. We next subjected these cells to TR-FRET
(time-resolved fluorescence resonance energy transfer) cell-
based assays for estimating second messengers or byproducts
of GPCR signaling (cAMP and inositol phosphate IP1, a break-
down product of IP3). Adenylyl cyclases are primarily activated
by Gas, but can also be differentially regulated by Gbg or Ca
2+218 Cell 152, 210–223, January 17, 2013 ª2013 Elsevier Inc.(Sunahara and Taussig, 2002), so it is important to assay down-
streamactivationofbothGai/o andGaq/11pathways, respectively.
For assaying Gai/o activity, the cells were simultaneously treated
with forskolin (which activates adenylyl cyclases) to increase
basal cAMP levels. To assay Gaq/11 activity, we estimated IP1
levels. Gpr161 was strongly induced under the experimental
conditions (Figures 7C and S7B). Out of the assay formats for
measuring cAMP and IP1 levels, we only detected a significant
increase in cAMP levels in induced cells, either in the absence
or presence of forskolin (T-REx-293 cells: Figures 7A and 7B;
NIH 3T3 Tet-on 3G cells: Figure S7A). The increase in basal
cAMP levels in induced cells was40% to70%of cAMP levels
detected upon forskolin treatment in uninduced T-REx-293 and
NIH 3T3 Tet-on 3G cells, respectively. As our assays rule out
Gai/o or Gaq/11 activity, Gpr161 is likely to be Gas coupled. We
tested this directly by knocking down Gas in T-REx-293 cells
using two different siRNAs. Upon treatment with either of these
siRNAs, we detected less than 30% residual protein (Figure 7D
inset) and an 50% reduction in the basal cAMP activity of
Gpr161, suggesting that Gpr161 is primarily coupled to Gas (Fig-
ure 7D). As Gpr161 overexpression and constitutive activity
results in increased cAMPconcentration,wepredict that itsmajor
role in antagonizing Shh signaling is via activating PKA.
To construct an inactive mutant of Gpr161, we considered
specific mutations previously characterized in GPCRs. The
mutation V147E in the second intracellular loop (following the
‘‘D[E]RY’’ motif, DRYxxV) of the closely related hamster a1b-
adrenergic receptor results in a complete loss of receptor-
mediated signaling, whereas mutations of the homologous
valine in IL8RA result in a profound impairment of its coupling
to Gai (Damaj et al., 1996; Greasley et al., 2001). We therefore
generated inducible stable lines expressing the homologous
valine in Gpr161 mutated to glutamate (V158E). We did not
detect any increase in cAMP upon induction (Figures 7A, 7B,
and S7A), although the increase in protein levels was similar to
the wild-type receptor in two separate cell lines (Figures 7C
andS7B), suggesting that the V158Emutation completely blocks
constitutive receptor activity.
DISCUSSION
Gpr161 Is a Key Negative Regulator of Shh Signaling
Tulp3 and IFT-A mutants exhibit ventralized phenotypes in the
neural tube compared to the dorsalized phenotype of other IFT
machinery mutants that affect ciliary assembly. We previously
showed that Tulp3 binds to the core IFT-A subcomplex and
predicted that trafficking of a ciliary GPCR by Tulp3 could
mediate the effect of Tulp3/IFT-A in antagonizing Shh signaling
(Mukhopadhyay et al., 2010). In the present study, we have
identified such an orphan class A GPCR, Gpr161, which is
conserved in vertebrates and is critical for neural tube
patterning. We show that endogenous Gpr161 is localized to
cilia in a wide variety of cells and requires Tulp3/IFT-A for ciliary
trafficking. During mouse embryonic development, Gpr161 is
expressed ubiquitously as early as E8.5 and is mostly con-
centrated in the developing nervous system at later stages.
Most importantly, a null knockout allele for Gpr161 results in
embryonic lethality by E10.5 and generally phenocopies but
is more extensive than the Tulp3/IFT-A mutants by causing
increased Shh signaling and ventralization throughout the
developing neural tube. Thus, our results describe the role of
a Tulp3/IFT-A-regulated GPCR in mammalian Shh signaling.
The complete absence of limb buds in Gpr161 knockout
mutants suggests that, in addition to the Shh pathway, it
functions in other morphogenetic pathways that affect limb
development.
Gpr161 Regulates Processing and Stability of Gli
Proteins through cAMP Signaling
How does Gpr161 affect Shh signaling? Both Sufu and PKA
regulate the processing and/or stability of Gli3/2 proteins.
Gpr161 knockout embryos exhibit decreased processing of
Gli3 into Gli3R and reduced levels of both Gli3/2 full-length
proteins, which is strongly reminiscent of either PKA null or
Sufu mutants, although phenotypes in these mutants are more
severe (with embryonic lethality by E9–9.5 and dramatic reduc-
tion in levels of Gli3/2 full-length protein) (Tuson et al., 2011;
Wang et al., 2010). Which of these two pathways could mediate
the effects of Gpr161 on Gli3 processing? First of all, Gpr161
overexpression and constitutive activity result in increased
cAMP levels, which would strongly facilitate increased PKA
activity, suggesting that the primary effect of Gpr161 is mediated
through PKA. Our cAMP/IP1 and Gas knockdown assays
suggest that Gpr161 is likely to be Gas coupled. Notably, Gas
has been recently described to be present in mammalian ciliary
proteome (Ishikawa et al., 2012). Second, primary cilia are not
required for Sufu to inhibit Gli activity (Chen et al., 2009; Humke
et al., 2010; Jia et al., 2009), whereas the neural tube phenotype
in the Gpr161 mutant is dependent on the anterograde IFT
motor kinesin II, suggesting that the effects of Gpr161 are notmediated primarily through the action of Sufu. The effect of
Gpr161 (and Tulp3/IFT-A) (Norman et al., 2009; Qin et al.,
2011) on ventralization of the neural tube occurs largely indepen-
dent of Smo (which is critically important in the Shh-activation
machinery). This also reinforces the idea that the primary effect
of Gpr161 is in ‘‘tuning’’ the PKA-dependent basal repres-
sion machinery in Shh signaling by modulating cAMP levels
(Figure 7E).
Gpr161 Internalization upon Shh Signaling
An important aspect of Shh signaling is the ‘‘resetting’’ of the
‘‘off’’ switch by removal of both Ptch1 and Gpr161 from the cilia
(Figure 7E). Ptch1 directly binds to Shh, and this step is critical in
its ciliary exit (Rohatgi et al., 2007). In contrast, the internalization
of Gpr161 occurs upon treatment with Shh or agonists of Smo,
i.e., active Shh signaling. However, Gpr161 does not bind to
Ptch in coimmunoprecipitation assays (data not shown). Further,
in contrast to Ptch1, Gpr161 is not a transcriptional target of the
Shh pathway (data not shown), and thus Gpr161 removal from
the cilia constitutes a positive feedback loop restricting its
function during active Shh signaling. Gpr161 is internalized into
the endosomal recycling compartment upon Shh signaling and
is not apparently degraded. Further studies into mechanisms
of internalization of Gpr161 promise to provide us with important
insights into pathways regulating GPCR levels in the ciliary
compartment.
Role of Cilia as a Regulatable Platform during Shh
Signaling
Although we cannot formally rule out the possibility of Gpr161
functioning in cAMP/PKA-mediated regulation of Shh signaling
in the absence of cilia, the localization of both Gpr161 and Gas
in the cilia suggests them to be, at least, functional in this cellular
compartment. This also brings us to the broader issue of the
requirement of the primary cilium for organizing Shh signaling
in vertebrates. Clearly, the components of the basal repression
machinery, including both Ptch1 and Gpr161, are ciliary and
are actively removed from cilia in a Shh-dependent manner. In
this case, the cilia probably acts as a platform amenable to rapid
‘‘resetting.’’ The cilium also acts as a trafficking platform for Gli3/
2 processing (Haycraft et al., 2005; Humke et al., 2010; Wen
et al., 2010). Besides, PKA is localized to the cilium base and
plays an essential role in integrating Shh signals (Tuson et al.,
2011) for Gli processing. As basal activity of Gpr161 causes
increased cellular cAMP levels, and it localizes to the cilium in
the absence of Shh, it is a candidate GPCR for establishing
this basal cAMPgradient. The identification of the ciliary localiza-
tionmotif and our ongoing studies on the internalization and acti-
vation motifs in Gpr161 will provide us with critical parameters to
test in order to address the precise role of Gpr161 in establish-
ment of the spatiotemporal cAMP gradient and the function of
cilia as a regulatable platform during vertebrate Shh signaling.
EXPERIMENTAL PROCEDURES
Mouse Strains
Heterozygous mice harboring the Gpr161 allele were obtained from Taconic/
Lexicon Pharmaceuticals. The Gpr161 knockout was generated by geneCell 152, 210–223, January 17, 2013 ª2013 Elsevier Inc. 219
Figure 7. Basal Activity of Gpr161 Results in Increased cAMP Levels
(A) T-REx-293 cells stably expressing untagged Gpr161 or Gpr161V158E mutant were induced for 24 hr with 2 mg/ml Doxycycline. The cells were treated with
nonselective phosphodiesterase inhibitor IBMX (1 mM) ± forskolin (2 mM) for last 45 min and then subjected to TR-FRET cell-based assays for assaying cAMP.
Data are from three independent experiments and are represented as mean ±SEM. cAMP levels in each experiment were calculated as % values of uninduced
Gpr161-expressing cells treated with forskolin. *p < 0.05.
(legend continued on next page)
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targeting of the third exon (NM_001081126.1) via homologous recombination
in mouse ES cells of the 129/SvEv strain and then by injecting host embryos
of the C57BL/6 albino strain. The targeted recombination results in deletion
of most of the third exon, except its initial 44 bp. This results in truncation of
Gpr161 after its initial 30 amino acids, encompassing only the predicted signal
sequence (NP_001074595.1). Genotyping of Gpr161 allele was performed
using primers in the deleted third exon (P1; 50GTCTCTGAGTTCATCGCC
ATCA), flanking the 30 end of the deleted exon (P2; 50AGATCCCTCATTCCGT
AACCCT) and in the Neo cassette (Neo3a, 50GCAGCGCATCGCCTTCTATC).
Wild-type band was 345 bp, and the mutant band was 208 bp (Figure S2B).
Targeted deletion was also confirmed by Southern analysis by Lexicon (data
not shown). The heterozygous mice were bred into a C57BL6/N background
and backcrossed four times. No difference in the Gpr161 mutant phenotype
was observed on either the mixed background (or during crossing with other
strains) or after backcrossing into the C57BL6/N background. Other mouse
strains used include Smotm1Amc (Zhang et al., 2001) and Kif3Atm1Gsn (Marsza-
lek et al., 1999).
Antibodies and Reagents
A C-terminal peptide from mouse Gpr161 (Cys-RGSRTLVNQRLQLQSIKE
GNVLAAEQR-COOH) was used as an immunogen for raising polyclonal
antibody against Gpr161 and was affinity purified using standard protocols
(YenZym). Details of other antibodies, plasmids, reagents, and generation of
stable cell lines are in Extended Experimental Procedures.
In Situ Hybridization, Scanning EM, Immunofluorescence,
and Microscopy
In situ hybridization (ISH) experiments using radiolabeled and digoxigenin-
labeled probes, scanning EM, immunofluorescence of cultured cells, and
embryo cryosections were performed according to standard protocols and
are described in Extended Experimental Procedures.
GPCR Immunoblotting and Immunoprecipitation
T-REx-293 Gpr161 or Gpr161V158E cells were harvested by scraping and were
snap frozen in liquid N2. Lysis was done in a GPCR lysis buffer (1% digitonin in
TBS [150 mM NaCl, 50 mM Tris, pH 7.5] with freshly added protease and
phosphatase inhibitors) for an hour. After clarifying the lysate at 16,000 3 g
for 10 min, equivalent amounts of low-speed supernatant were treated with
2 3 urea sample buffer (4 M urea, 4% SDS, 100 mM TrisHCl [pH 6.8], 0.2%
bromophenol blue, 20% Glycerol, 200 mM DTT) at room temperature.
Samples were loaded to 4%–12% Bis-Tris NuPAGE gels within 15 min and
were immunoblotted using standard procedures. For immunoprecipitation
experiments, T-REx-293 Gpr161 cells were transfected with C-terminal
Flag-tagged pRK5-PTCH1 construct and were induced for 48 hr. After
harvesting and snap-freezing cells, cells were lysed for 1 hr in the previous
GPCR lysis buffer with added 0.05% cholesterol hemisuccinate (CHS) and
0.25% dodecyl maltoside (DDM) and were clarified as mentioned previously.
Simultaneously, anti-FLAG M2-affinity beads were washed in TBS and were
washed in 0.1 M Glycine, pH 3.5. After rewashing in TBS, the beads were(B) Same cells were induced as in (A), treated with IP stimulation buffer (Experime
assays for assaying IP1. Data are from two experiments and are represented a
uninduced Gpr161-expressing cells.
(C) Same cells were induced as in (A) and immunoblotted for indicated proteins.
(D) T-REx-293 cells stably expressing untagged Gpr161 were transfected with in
FRET cAMP assays. Levels of cAMP in each siRNA-transfected cohort were norm
represented as mean ±SD; *p < 0.05 with respect to control siRNA-treated induce
uninduced cells upon siRNA transfection for 96 hr. The Gas antibody detects bot
predominant smaller isoform are given below the immunoblots.
(E) Model for the role of Gpr161 in the Shh pathway. In the absence of Shh, Gp
knockout phenocopies Tulp3/IFT-A mutants by causing increased Shh signaling
reduced upon knockdown of Gas, suggesting it to be a Gas-coupled receptor. Th
Gli3R levels in the Gpr161 mutant. Ligand binding could potentially modulate the
mark). In the presence of Shh, Gpr161 is removed and internalized from the cilia, p
Gli3R, Gli3 repressor.
See also Figure S7.added to the clarified lysates for 3 hr. The beads were washed thrice in the
same lysis buffer and were treated with 2 3 urea sample buffer as mentioned
above. Immunoblotting was performed for FLAG and Gpr161. For preparation
of the lysis buffers, 1%digitoinin was added to TBS from a 10% stock and was
used within 7 days of preparation. The CHS/DDM 40 3 stock solution was
prepared by sonicating during solubilization. Embryos were processed for
Gli1/2/3 immunoblotting as described previously (Wen et al., 2010).
TR-FRET cAMP and IP1 Assays
To measure the activation of Gs/i/o and Gq/11, we used cell-based TR-FRET-
based cAMP dynamic 2 and IP-One HTRF commercial assays to measure
cAMP and IP1, respectively (Cisbio). The TR-FRET assay eliminates the back-
ground noise due to FRET-based estimation of signals. Besides, the use of
long-lived fluorophores (in this case, lathanides), combined with time-resolved
detection (a delay between excitation and emission detection), minimizes
prompt intrinsic fluorescence interferences (Degorce et al., 2009). T-REx-
293 Gpr161 or Gpr161V158E cells were plated on 96 well poly-D-lysine-coated
plates and induced with doxycycline (2 mg/ml) for 24 hr. Similarly, NIH 3T3
Tet-on 3G cells stably expressing untagged Gpr161 or Gpr161V158E mutant
were induced for 24 hr with doxycycline in serum starvation media (containing
0.5% FBS). For the cAMP assays, cells were finally treated with the nonselec-
tive phosphodiesterase inhibitor IBMX (1 mM) with or without addition of
forskolin (2 mM) as mentioned in the legends (Figures 7A and S7A). For the
IP1 assay, cells were finally treated with IP stimulation buffer (Cisbio; HEPES
10 mM, 1 mM CaCl2, 0.5 mM MgCl2, 4.2 mM KCl, 146 mM NaCl, 5.5 mM
glucose, LiCl 50 mM [pH 7.4]) for 45 min. Individual treatments were run in
each experiment in triplicate. The final FRET counts were recorded using an
EnVision 2103 multiplate reader (Perkin Elmer). Standard curves were gener-
ated using least-squares fitting method (with R2 value > 0.99), and values for
unknowns were interpolated using Graphpad Prism 5.
Statistical Analyses
Statistical analyses were performed using one-way analysis of variance
(ANOVA) and Tukey-Kramer’s post hoc multiple comparison tests between
all possible pairs in each data set (Figures 5C, 6B, and S6), whereas Student’s
t test was used for comparing groups (Figures 1B, 1C, 3A, 3B, 7A, 7B, 7D, S2,
and S3) using JMP 9 statistical analyses package.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and sixmovies and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2012.12.026.
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